Evidence map›Paper›PMID 36017769›Full record

ArticleOrthopaedic surgery2022

Mortality and Related Risk Factors of Fragile Hip Fracture.

Pei-Wen Wang, Xue-Dong Yao, Hua-Feng Zhuang, Yi-Zhong Li, Hao Xu, Jin-Kuang Lin, Wen-Ge Liu

Open access · goldAbstract read
In one paragraph

Article in Orthopaedic surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Pei-Wen Wang *Department of Orthopaedic Surgery, The Second Affiliated Hospital, Fujian Medical University, Quanzhou, China.
Xue-Dong Yao *Department of Orthopaedic Surgery, The Second Affiliated Hospital, Fujian Medical University, Quanzhou, China.
Hua-Feng ZhuangDepartment of Orthopaedic Surgery, The Second Affiliated Hospital, Fujian Medical University, Quanzhou, China.
Yi-Zhong LiDepartment of Orthopaedic Surgery, The Second Affiliated Hospital, Fujian Medical University, Quanzhou, China.
Hao XuDepartment of Orthopaedic Surgery, The Second Affiliated Hospital, Fujian Medical University, Quanzhou, China.
Jin-Kuang LinDepartment of Orthopaedic Surgery, The Second Affiliated Hospital, Fujian Medical University, Quanzhou, China.
Wen-Ge LiuDepartment of Orthopaedic Surgery, The Affiliated Union Hospital, Fujian Medical University, Fuzhou, China.ORCID https://orcid.org/0000-0002-9062-6570
Fujian Medical University · CN

Funding

Innovative Talents Project of Science and Technology Plan of Quanzhou 2018C046RNatural Science Foundation of Fujian Province 2020J01211
6 · The paper itself

Abstract

objectiveTo explore the mortality of patients with fragile hip fractures and assess the death-associated risk factors.

methodsA total of 690 patients with osteoporotic hip fractures (age, 50-103 years) that were treated from January 2010 to December 2015 were enrolled and followed-up in this study and the clinical data were retrospectively collected. Three months, 1 year, and the total mortality were measured. Mortality-related risk factors were assessed including age, gender, surgery, the duration from injury to operation, pulmonary infection, and the number and type of complications. The mortality of each group was compared by chi-square test or corrected chi-square test for univariate analysis, and the factors with statistically significant mortality difference confirmed by univariate analysis were analyzed by binary logistic multivariate analysis.

resultsThe 3-month mortality was 7.69%, the 1-year mortality was 15.60%, and the total mortality of the follow-up time was 24.06%. The 1-year and total mortality during the follow-up of the patients were higher in the >75-year-old group than those in the ≤75-year-old group (p = 0.000, respectively); were higher in the male patients than that in the female patients (p = 0.042; p = 0.017, respectively); were significantly lower in the operation group than that in the non-operation group (p = 0.000, respectively); were significantly lower in the patients that underwent the operation in ≤5 days than the patients that underwent the operation within >5 days (p = 0.008; p = 0.000, respectively); were significantly lower in patients with >2 kinds of combined medical diseases than those with ≥2 kinds of chronic diseases (p = 0.000, respectively); were significantly lower in patients receiving anti-osteoporosis treatment than in patients not receiving anti-osteoporosis treatment (p = 0.000, p = 0.002, respectively). Binary logistic regression analysis showed that the independent risk factors affecting mortality included advanced age >75-years-old (OR = 5.653, p = 0.000), male (OR = 1.998, p = 0.001), non-surgical treatment (OR = 9.909, p = 0.000), the number of combined medical diseases ≥2 (OR = 1.522, p = 0.042), and non-anti-osteoporosis treatment (OR = 1.796, p = 0.002).

conclusionAge, whether or not surgical treatment was performed, the number of medical diseases, and whether or not anti-osteoporosis treatment was performed were independent risk factors for 3-month and 1-year mortality in patients with fragile hip fractures.

Indexed as

Hip FracturesOsteoporotic FracturesAgedAged, 80 and overFemaleHumansMaleMiddle AgedRetrospective StudiesRisk Factorsfragile fractureshipmortalityrisk factorstreatment

Identifiers

PMID36017769
PMCPMC9531092
OpenAlexW4293194352

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.